CHARLES A. HALL, M.D.; KENNETH B. OLSON, M.D.
The course of a malignant lymphoma varies widely from patient to patient. Some patients do not respond to any therapy and die within a few months. Many have remissions of a few months, respond less and less with future therapy, and die in from two to three years after the diagnosis is made. Some have a course similar to that of the latter group but remissions are longer, spread of the disease is slower, and they live five, 10 or 15 years. In some cases these patients have a long remission from a single course of therapy and then
CHARLES A. HALL, KENNETH B. OLSON. PROGNOSIS OF THE MALIGNANT LYMPHOMAS(PROGNOSIS OF THE MALIGNANT LYMPHOMAS*). Ann Intern Med. 1956;44:687–706. doi: 10.7326/0003-4819-44-4-687
Download citation file:
Published: Ann Intern Med. 1956;44(4):687-706.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use